In the U.S., HPV infections are estimated to cause about 37,300 cases of cancer. The HPV vaccine can prevent over 90% of these cancers from ever developing.
One important prevention tool against sexually transmitted infections is vaccination. Currently, vaccines are available to protect against infection with HPV, hepatitis A and hepatitis B.
A Phase 1 trail for a possible new chlamydia vaccine had encouraging results. Chlamydia is one of the most common STIs worldwide—a vaccine could dramatically change this landscape.
A new study revealed a disturbing trend in health knowledge; fewer people seem to understand the connection between HPV and certain types of cancer including cervical, oral, anal, and penile cancers.